Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Kappa agonists developed at Warner-Lambert

April 15, 1998

Anticonvulsant drugs: a new treatment alternative for psychiatric disorders

April 15, 1998

Radical-scavenging furan nitrone compounds in the pipeline at Centaur

April 14, 1998

Adenosine antagonists for CNS, cardiovascular and other disorders

April 14, 1998

Interneuron receives fast track designation for CerAxon

April 9, 1998

MS&D describes novel class of antimigraine agents

April 9, 1998

Advisory committee meeting cancellation announced

April 8, 1998

Abbott discovers new agents for controlling synaptic transmission

April 8, 1998

Study shows Quadramet provides significant relief from bone pain

April 8, 1998

Warner-Lambert announces collaboration with Forest

April 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...